Validation of BIVA for Nutritional Assessment in Cirrhotic Patients
Validation of Bioelectrical Impedance Vector Analysis for Nutritional Assessment in Patients With Cirrhosis
1 other identifier
observational
250
1 country
1
Brief Summary
Despite the importance of nutritional status in patient's outcome, there is no gold standard for nutritional assessment. Traditional techniques used in healthy subjects to assess nutritional status cannot be used in cirrhotic patients due especially to ascites and peripheral edema, and altered rates of biochemical markers due to liver failure. Bioelectrical impedance vector analysis has emerged as a useful method to assess body composition and nutritional status especially in patients at the extremes of body weight (fluid overload, excess of adipose tissue, etc.). With previous results from our research group, BIVA showed to be useful for evaluating cirrhotic patients. The aim of this study is to validate our previous results and validate BIVA for nutritional assessment in patients with liver cirrhosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 24, 2013
CompletedFirst Posted
Study publicly available on registry
June 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 10, 2016
October 1, 2016
6.5 years
May 24, 2013
October 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in nutritional status
It will be assessed by bioelectrical impedance vector analysis
At the time of inclusion, every six months up to 36 months
Other Outcomes (1)
Evaluation of mortality
Through study completion, an average of 36 months.
Eligibility Criteria
The participants will be recruited from the Gastroenterology Department of a tertiary care setting.
You may qualify if:
- Diagnose of liver cirrhosis by two or more of the following criteria:
- Albumin \< 3.4 g/dL
- INR ≥ 1.3
- Total bilirubin ≥ 2 mg/dL
- Portal hypertension (esophageal varices, splenomegaly, ascites, etc.)
- Liver biopsy
- Ambulatory patients
You may not qualify if:
- Personal history of surgery in the last four weeks
- Thyroid disorders without replacement therapy
- Pregnancy
- Active alcoholism with alcohol ingest in the previous 6 months.
- Acute or chronic renal failure
- Hepatic or renal transplant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"
Mexico City, 14000, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Aldo Torre, MD, MSc
Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"
- PRINCIPAL INVESTIGATOR
Astrid Ruiz-Margain, BSc, MSc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- PRINCIPAL INVESTIGATOR
Ricardo Macías-Rodriguez, MD, MSc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., M.Sc.
Study Record Dates
First Submitted
May 24, 2013
First Posted
June 7, 2013
Study Start
January 1, 2010
Primary Completion
July 1, 2016
Study Completion
September 1, 2016
Last Updated
October 10, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share